About 2,200 results
Open links in new tab
Targeted Oncology - Immunotherapy, Biomarkers, and Cancer …
Mirdametinib Scores FDA Priority Review in Neurofibromatosis …
The Promise of IL-21 Engineered NK Cells in Glioblastoma Treatment
Adjuvant T-DM1 Continues to Outperform Trastuzumab in HER2 …
FDA Acknowledges BLA of Zolbetuximab in HER2–, CLDN18.2
DLBCL - targetedonc.com
Nadofaragene Firadenovec Now Fully Available for BCG …
FDA Grants Priority Review to BLA of Afami-cel in Synovial Sarcoma
Recent Approvals Signal a Bright Future for Myelodysplastic …
Jordyn Sava - Targeted Oncology